FMS Fresenius Medical Care AG
XNYS
22.96
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
FMS
$22.96
—
What changed
Recent filings, trades and movesKey stats
$22.96
- 52-Week Range
- $20.02 – $26.42
- YTD
- -2.35%
- IV Rank (30D)
- 10.12
- Straddle Price
- $1.77
- P/C Vol Ratio
- 1.45
- Market Cap
- $12.1B
- Open
- $23.05
- Day Range
- $22.89 – $23.09
- Volume
- 630,289
- Prev Close
- $23.40
Fair Value
MODEL: NEUTRAL
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.90% |
| Beta vs SPY | 0.64 |
| Cost of Equity (CAPM) | 8.09% (VRP-adj) |
| WACC | 5.50% |
| Volatility Risk Premium | +24.3pp (IV − HV30) |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +3.0% |
| DCF Horizon | 5 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.03 (applied to P/E, EV/EBITDA, P/S) |
| Book / Price | 138.0% — banking bias active (P/B is primary) |
| Debt / Equity | 0.40 |
| Quality Score | 1/6 — cyclical/struggling (5y DCF) |
| SMA 50 | $22.34 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $22.30 |
| Bollinger Width / SMA20 | 12.8% (drives anchor stability) |
| Net Debt | $4.8B |
| Market Cap | $12B |
Peers used for multiples: BAX, BMY, CVS, HUM, PFE, SOLV, SWKS, UHS
60-Day Conviction
19%
20-Day Fair Value
≈ by Dec 8, 2026
$22.99
α +0.1%
rank 74%
conviction
4%
40-Day Fair Value
≈ by Jan 6, 2027
$23.32
α +1.5%
rank 74%
conviction
52%
60-Day Fair Value
≈ by Feb 4, 2027
$22.82
α -0.7%
rank 74%
conviction
19%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | $17.47 | 28% | |
| Peer P/E | n/a | 0% | median 13.9× · 7 peers |
| Peer EV/EBITDA | n/a | 0% | median 14.1× · 8 peers |
| Peer P/B | $74.42 | 11% | median 2.3× · 8 peers |
| Peer P/S | n/a | 0% | median 1.5× · 8 peers |
| Market Anchor (SMA50) | $22.34 | 61% | stability 86% (BB-width) |
| Options Expected (B-L 30d) | $21.93 | 0% | 5 strikes · skew -0.78 |
As of 2026-11-09 · updated
Related
About
- Industry (SIC)
- SERVICES-MISC HEALTH & ALLIED SERVICES, NEC (8090) · industry map
- Exchange
- XNYS
- Market Cap
- $12.1B
- Employees
- 108,165
- List Date
- 1996-09-17
- CIK
- 0001333141
- Homepage
- https://www.freseniusmedicalcare.com
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -5.36% | 3.71% | 16.26% | -9.18% | 12.28% | -3.45% | 2.38% |
| Feb | -11.45% | -6.48% | 3.80% | -2.34% | -0.82% | 3.81% | -2.25% |
| Mar | 5.25% | 8.02% | 12.67% | -0.41% | 5.73% | -3.88% | 4.56% |
| Apr | 8.69% | -8.25% | 12.44% | 10.21% | 2.59% | 0.98% | 4.44% |
| May | -0.57% | -1.13% | -10.71% | 0.24% | 13.51% | -4.09% | -0.46% |
| Jun | 4.16% | -15.29% | 11.15% | -10.21% | -0.80% | 7.46% | -0.59% |
| Jul | -5.80% | -26.24% | 9.94% | 0.63% | -11.92% | 11.98% | -3.57% |
| Aug | 0.57% | -6.81% | -7.24% | 3.36% | 2.27% | -9.98% | -2.97% |
| Sep | -10.08% | -16.87% | -9.42% | 10.94% | 8.09% | -1.58% | -3.15% |
| Oct | -5.70% | -2.46% | -22.00% | -8.05% | 0.83% | 0.94% | -6.07% |
| Nov | -12.40% | 14.10% | 22.81% | 11.44% | -9.22% | 1.64%* | 4.73% |
| Dec | 7.95% | 2.25% | 0.53% | -0.61% | 0.72% | -- | 2.17% |
| Total | -24.58% | -47.65% | 34.97% | 2.97% | 22.09% | 2.06% | -1.69% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $22.39
SMA 50: $22.33
SMA 200: $22.91
Current: $22.97
EMA 12: $22.78
EMA 26: $22.52
MACD: 0.2534 | Signal: 0.1259
BULLISH
ADX (14): 12.32
RANGE
+DI: 34.99
−DI: 32.76
Momentum Oscillators
RSI (14): 54.02
NEUTRAL
Stoch %K: 81.11
Stoch %D: 83.29
Williams %R: -36.13
Volume & Volatility
BB Upper: $23.76
BB Lower: $21.02
NEUTRAL
OBV: -599,390
Vol SMA 20: 1,387,436
Vol ROC: 9.98%
ATR: $0.60
True Range: $0.51
HV 20: 38.6%
HV 30: 41.2%
HV 60: 31.7%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-11-08T00:00:00 – 2026-11-06T00:00:00
AI Analysis
LLM Stock Analysis Report - FMS
Executive Summary
Overall assessment: NEUTRAL (Confidence level: 7/10)
Key drivers:
- Technical signals indicate a range-bound market with some bullish momentum
- Positive news sentiment from recent headlines, particularly in the healthcare and medical devices sectors
- Low volatility suggests reduced risk, but IV rank indicates historically low volatility
Primary risks:
- Negative earnings surprise or guidance could lead to a sell-off
- Regulatory changes or unexpected developments in the healthcare sector could impact FMS's business
Investment thesis: FMS appears to be trading within a range-bound market, with some bullish momentum and positive news sentiment. The stock's low volatility and historically low IV rank suggest reduced risk, making it an attractive investment opportunity for those willing to take on some risk.
Recent news sentiment impact: The recent headlines have been neutral or positive, which could support the stock price. However, a surprise negative earnings report or unexpected regulatory changes could negatively impact FMS's stock.
Technical Analysis
Trend Direction: Short-term (1-4 weeks): NEUTRAL, Medium-term (1-3 months): BULLISH, Long-term (3-12 months): BEARISH
Support/Resistance Levels: Key price levels from moving averages and technical patterns:
- SMA 20: $21.85
- SMA 50: $22.36
- SMA 200: $23.86
- EMA 12: $21.86
- EMA 26: $22.06
Momentum Signals:
- RSI interpretation (overbought >70, oversold <30, neutral 30-70): NEUTRAL (44.47)
- MACD signal (bullish/bearish crossover): BEARISH (-0.20 / Signal: 0.01 / Histogram: -0.21)
- Bollinger Bands position (squeeze, breakout, mean reversion): MEAN REVERSAL
Volume Analysis: Volume trends and institutional interest signals:
- Volume SMA 20: 912816.55
- On-Balance Volume (OBV): 275331.28
- Volume Rate of Change: 55.43%
News & Sentiment Analysis
Recent Headlines Summary: Key themes from last 10 news articles:
- Healthcare and medical devices sector trends
- Government funding and initiatives for healthcare research and development
- Patient preference for non-invasive solutions in healthcare
Sentiment Assessment: Aggregate news sentiment (positive/negative/neutral): NEUTRAL to POSITIVE
Catalyst Identification: Upcoming events, earnings, product launches, regulatory changes:
- No specific catalysts identified based on recent news headlines
Risk & Volatility Assessment
Beta Interpretation: Risk relative to market (beta >1.2 = high risk, <0.8 = defensive): 0.51 (low volatility)
Volatility Regime: Current vs historical volatility levels: LOW VOLTILITY
Options Market Signals: IV rank, put/call ratios, unusual activity:
- IV Rank: 0.0% (Low - shows if volatility is historically high/low)
- Current IV: 43.6%
- Expected Move: $4.50 (22 DTE), 7-DTE: $4.50
- Volume Flow: 31 calls vs 17 puts
- Open Interest: 1,016 calls vs 54 puts
- Put/Call Volume Ratio: 0.55 (Bullish sentiment)
- Put/Call OI Ratio: 0.05
Market Context & Positioning
Sector Performance: Relative strength vs sector/market:
- Healthcare and medical devices sector has been performing well, which could support FMS's stock price
Institutional Activity: Volume patterns suggesting institutional interest signals:
- Institutional investors have been buying the stock, as evidenced by the increasing open interest in options
Correlation Analysis: How stock moves relative to market (R-squared interpretation):
- FMS has a low correlation coefficient with the broader market, indicating reduced volatility and potential for higher returns
Relative Valuation: Position within trading range:
- FMS appears to be trading within a range-bound market, with some bullish momentum and positive news sentiment
Key Levels & Action Items
Critical Price Levels: Support/resistance to monitor:
- SMA 20: $21.85
- SMA 50: $22.36
- SMA 200: $23.86
Breakout/Breakdown Levels: Technical levels that could trigger significant moves:
- If FMS breaks above the SMA 200, it could indicate a longer-term bullish trend and potential for higher returns
- If FMS breaks below the SMA 50, it could indicate a bearish trend and potential for lower returns
Time-Sensitive Catalysts: Earnings dates, FDA approvals, product launches:
- No specific time-sensitive catalysts identified based on recent news headlines
Risk Management: Stop-loss levels and position sizing considerations:
- Consider setting a stop-loss at the SMA 50 level to limit potential losses
- Position size should be adjusted based on risk tolerance and market conditions
Generated
News
All FMS news →
CEO Korangy tackles reimbursement headwinds while advancing 5008X rollout.
FMS Options Activity & IV Rank
FMS IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 36.7%
7-DTE IV: 70.6%
Expected Move: $1.77
7-DTE Move: $2.08
Days to Exp: 39 (2026-12-18)
Options Flow · All expiries
Call Volume: 372
Put Volume: 539
P/C Volume: 1.449
BEARISH
Call OI: 1,910
Put OI: 3,985
P/C OI: 2.086
Total OI: 5,895
ATM Options Pricing
ATM Call: $1.12
ATM Put: $0.65
Call %: 4.9%
Put %: 2.8%
Chain Summary
Chain Volume: 911
Chain OI: 5,895
Last Updated: 11/9/2026
Spread Scanner
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Dealer Positioning
LOW γ vs HISTORY
Estimated net dealer gamma is at the 8th percentile of this name's own daily history, near the low end of its range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
8%
vs own history
GEX tilt
-0.47
OI-weighted, today
Vanna tilt
+0.28
δ-sensitivity to IV
Charm tilt
-0.85
δ-decay vs time
Charm tilt -0.85: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 8 ATM contracts, 5k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
No data
30 DTE / 10d
—
—
pts
EXTREME
No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Loading the implied volatility surface…
Volatility Smile
Loading the implied volatility smile…
IV Rank (7 DTE)20.9LowNov 9
IV Rank (30 DTE)10.1LowNov 9
Straddle Price (30 DTE)$1.77Nov 9
Beta Analysis
Risk Metrics
Beta: 0.0939
Alpha: -0.73%
Correlation: 0.0420
R-Squared: 0.2%
Stock Volatility: 30.8%
Market Volatility: 13.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
FMS Institutional Ownership (13F)
Filings for 2026-06-30 · 114 already for 2026-09-30
? 13F Guide
Diluted shares outstanding: 291,190,575 (as of 2025-12-31)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
4 filers$1.74M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Optiver Holding B.V. | $531.34K | 30.56% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $447.68K | 25.75% | 2026-06-30 |
| 3 | Jane Street Group, LLC Custodian | $411.50K | 23.67% | 2026-06-30 |
| 4 | Susquehanna International Group, LLP Custodian | $348.19K | 20.03% | 2026-06-30 |
4 filers$2.71M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $1.77M | 65.41% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $472.55K | 17.46% | 2026-06-30 |
| 3 | Jane Street Group, LLC Custodian | $253.23K | 9.36% | 2026-06-30 |
| 4 | Simplex Trading, LLC Custodian | $210.37K | 7.77% | 2026-09-30 |
ETF Holders
10 ETFs hold FMS
10 shown · $8.83M total exposure · 0.00% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | PXF Invesco RAFI Developed Markets ex-U.S. ETF | Nport | 0.10% | $2.7M | — | 2026-07-31 |
| 2 | PZLV Pzena U.S. Large Cap Value ETF | Nport | 2.80% | $2.0M | — | 2026-08-31 |
| 3 | AVDE Avantis International Equity ETF | Avantis | 0.01% | $1.7M | $19.3B | 2026-11-05 |
| 4 | BFLX iShares Flexible Equity Active ETF | iShares (BlackRock) | 0.06% | $1.2M | $2.1B | 2026-11-06 |
| 5 | APIE ActivePassive International Equity ETF | Nport | 0.06% | $698,527 | — | 2026-08-31 |
| 6 | TIIV AAM Todd International Intrinsic Value ETF | Nport | 1.11% | $365,373 | — | 2026-07-31 |
| 7 | DFAI Dimensional International Core Equity Market ETF | Dimensional | 0.00% | $83,189 | $17.9B | 2026-11-05 |
| 8 | DFIV Dimensional International Value ETF | Dimensional | 0.00% | $35,064 | $22.0B | 2026-11-05 |
| 9 | AVSD Avantis Responsible International Equity ETF | Avantis | 0.00% | $15,166 | $370.9M | 2026-11-05 |
| 10 | AVNC Avantis All International Core Equity ETF | Avantis | 0.00% | $4,188 | $96.1M | 2026-11-05 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
—
TTM Revenue
—
TTM Net Income
—
TTM Op. Cash Flow
—
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q4 '25 | 2025-12-31 | — | — | — | — |
| Q4 '24 | 2024-12-31 | — | — | — | — |
| Q4 '23 | 2023-12-31 | — | — | — | — |
| Q4 '22 | 2022-12-31 | — | — | — | — |
| Q4 '21 | 2021-12-31 | — | — | — | — |
| Q4 '20 | 2020-12-31 | — | — | — | — |
| Q4 '19 | 2019-12-31 | — | — | — | — |
| Q4 '18 | 2018-12-31 | — | — | — | — |
| Q4 '17 | 2017-12-31 | — | — | — | — |
| Q4 '16 | 2016-12-31 | — | — | — | — |
| Q4 '15 | 2015-12-31 | — | — | — | — |
| Q4 '14 | 2014-12-31 | — | — | — | — |
Q4 2025 • period ending 2025-12-31 • filed 2026-02-24
FMS vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| PFE Pfizer Inc. | $167.5B | 42.1 | +1.3% | +17.2% | 58 |
| BMY Bristol-Myers Squibb Co. | $127.0B | 13.8 | +3.1% | +17.0% | 38 |
| CVS CVS HEALTH CORPORATION | $107.3B | 9.9 | +6.8% | +6.1% | 33 |
| HUM Humana Inc. | $52.1B | 40.8 | +18.5% | +63.3% | 9 |
| SWKS Skyworks Solutions Inc | $19.3B | 43.2 | +0.1% | +29.4% | 40 |
| SOLV Solventum Corporation | $15.4B | 11.1 | −0.9% | +14.4% | 39 |
| BAX Baxter International Inc. | $13.3B | — | +5.3% | +35.0% | 35 |
| FMS Fresenius Medical Care AG | $12.1B | — | — | −2.3% | 10 |
| UHS Universal Health Services, Inc. Class B | $11.5B | 8.2 | +10.4% | −10.4% | 24 |
| Peer median | $35.7B | 13.8 | +4.2% | +17.1% | 36 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
3.96M
SI % of Float
0.74%
Days to Cover
3.51
Short Vol Ratio
69.1%
Free Float
—
Float %
—
Short interest 2026-10-15 • Short volume 2026-11-06